Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
RLX Technology
RLX
$2.46B
| $506K | ﹤0.01% |
279,725
-66,515
| -19% | -$114K |
|
3577
Sono-Tek
SOTK
$82.8M
| $505K | ﹤0.01% |
125,355
+12,900
| +11% | +$52.2K |
|
|
DNMR
3578
DELISTED
Danimer Scientific, Inc.
DNMR
| $503K | ﹤0.01% |
27,698
+2,342
| +9% | +$40.9K |
|
3579
Canterbury Park Holding Corp
CPHC
$80.1M
| $503K | ﹤0.01% |
26,045
+479
| +2% | +$9.73K |
|
3580
Nuvectis Pharma
NVCT
$617M
| $501K | ﹤0.01% |
79,716
+26,489
| +50% | +$174K |
|
3581
BuzzFeed
BZFD
$96.7M
| $500K | ﹤0.01% |
187,598
+29,543
| +19% | +$78.7K |
|
3582
Hycroft Mining Holding Corp
HYMC
$2.47B
| $494K | ﹤0.01% |
197,589
+22,302
| +13% | +$53.8K |
|
|
BGFV
3583
DELISTED
Big 5 Sporting Goods
BGFV
| $492K | ﹤0.01% |
235,346
+4,365
| +2% | +$9.32K |
|
|
FDSB
3584
Fifth District Bancorp
FDSB
$94M
| $492K | ﹤0.01% |
+47,442
| New | +$491K |
|
3585
PSQ Holdings
PSQH
$14.7M
| $490K | ﹤0.01% |
13,279
+2,952
| +29% | +$128K |
|
3586
Fuel Tech
FTEK
$43.7M
| $488K | ﹤0.01% |
464,826
+1,266
| +0.3% | +$1.3K |
|
|
KZR
3587
DELISTED
Kezar Life Sciences
KZR
| $485K | ﹤0.01% |
62,691
+8,168
| +15% | +$49.3K |
|
3588
Gain Therapeutics
GANX
$77.6M
| $484K | ﹤0.01% |
271,972
+88,236
| +48% | +$111K |
|
3589
Ondas Inc
ONDS
$5.19B
| $480K | ﹤0.01% |
622,595
+70,502
| +13% | +$57.8K |
|
3590
Milestone Scientific
MLSS
$42.6M
| $480K | ﹤0.01% |
527,005
+31,572
| +6% | +$29.6K |
|
3591
Brookfield Infrastructure Partners
BIP
$18B
| $479K | ﹤0.01% |
13,666
+270
| +2% | +$8.48K |
|
|
SOND
3592
DELISTED
Sonder
SOND
| $478K | ﹤0.01% |
102,142
+4,612
| +5% | +$20.4K |
|
3593
Mastech Digital
MHH
$93.2M
| $478K | ﹤0.01% |
47,753
+6,544
| +16% | +$59.6K |
|
3594
BayFirst Financial Corp
BAFN
$34M
| $475K | ﹤0.01% |
36,101
+2,490
| +7% | +$32.6K |
|
|
KLRS
3595
Kalaris Therapeutics
KLRS
$96.8M
| $474K | ﹤0.01% |
25,459
-2,692
| -10% | -$47.1K |
|
3596
Harte-Hanks
HHS
$16.9M
| $472K | ﹤0.01% |
63,463
+943
| +2% | +$7.4K |
|
|
IMA
3597
ImageneBio Inc
IMA
$64.6M
| $469K | ﹤0.01% |
22,586
+1,194
| +6% | +$24.1K |
|
3598
GH Research
GHRS
$2.08B
| $464K | ﹤0.01% |
69,421
-190
| -0.3% | -$1.95K |
|
3599
Lightpath Technologies
LPTH
$820M
| $464K | ﹤0.01% |
338,852
+1,028
| +0.3% | +$1.34K |
|
3600
John Wiley & Sons Class B
WLYB
$2.73B
| $464K | ﹤0.01% |
9,608
| – | – |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.